< Terug naar vorige pagina
Onderzoeker
Pieter Ruytinx
- Disciplines:Immunologie
Affiliaties
- Moleculaire Immunologie (Rega Instituut) (Labo)
Lid
Vanaf1 okt 2014 → 30 sep 2018
Publicaties
1 - 7 van 7
- Study of CXCL4 and CXCL4L1 isoforms in colon cancer: modulation of angiogenesis, monocytic stromal cell differentiation and tumor cell progression(2018)
Auteurs: Pieter Ruytinx, Sofie Struyf, Jo Van Damme
Aantal pagina's: 115 - CXCL4 and CXCL4L1 in cancer(2018)
Auteurs: Pieter Ruytinx, Paul Proost, Sofie Struyf
Pagina's: 65 - 71 - Intravital microscopic evaluation of the effects of a CXCR2 antagonist in a model of liver ischemia reperfusion injury in mice(2018)
Auteurs: Thiago Henrique Caldeira de Oliveira, Pedro Elias Marques, Fariba Poosti, Pieter Ruytinx, Paul Proost
Pagina's: 1917 - Relative distribution and biological characterization of CXCL4L1 isoforms in platelets from healthy donors(2017)
Auteurs: Pieter Ruytinx, Rik Janssens, Mieke Gouwy, Sandra Liekens, Paul Proost, Jo Van Damme, Sofie Struyf
Pagina's: 123 - 131 - Monocytes from patients with Primary Ciliary Dyskinesia show enhanced inflammatory properties and produce higher levels of pro-inflammatory cytokines(2017)
Auteurs: Maaike Cockx, Mieke Gouwy, Pieter Ruytinx, Inge Lodewijckx, Anneleen Van Hout, Jo Van Damme, Mieke Boon, Sofie Struyf
Pagina's: 14657 - Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes(2017)
Auteurs: Rik Janssens, Daiane Boff, Pieter Ruytinx, Mieke Gouwy, Olav Larsen, Sam Noppen, Sandra Liekens, Jo Van Damme, Sofie Struyf, Paul Proost
Pagina's: 92 - 101 - CXCL4 and CXCL4L1 differentially affect monocyte survival and dendritic cell differentiation and phagocytosis(2016)
Auteurs: Mieke Gouwy, Pieter Ruytinx, Sofie Struyf